GlassScriptPhysician profile
Charles Stoneburner
NPI 1609210129
$3,288.84
in general payments reported to CMS, 2019-2025
11 companies · $40.64 in 2025
The $40.64 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,677 · 2020: $37.46 · 2021: $402 · 2022: $282 · 2023: $465 · 2024: $384 · 2025: $40.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $980.18 | 2019 | |
| Cardiovascular Systems INC. | $704.83 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $439.80 | 2021-2022 | |
| Inari Medical, INC. | $417.00 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $219.16 | 2022-2023 | Embold Fibered |
| Penumbra, INC. | $188.11 | 2021-2024 | Indigo System, Ruby Coil, Penumbra System |
| Stryker Corporation | $184.23 | 2024-2025 | Ivas, Artix Mt, Flowtriever Catheter, S |
| Varian Medical Systems, INC. | $76.37 | 2021 | |
| Cardinal Health 200 LLC | $29.76 | 2020 | |
| Biosense Webster, INC. | $26.42 | 2023 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.98 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Stoneburner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.